Synapse - Radiation Oncology, Department of

Search Within

Radiation Oncology, Department of

Results (5279)

Phase I trial of adjuvant pembrolizumab after radiation therapy for lung-intact malignant pleural mesothelioma

Meeting Abstract

Ning, M. S.; Gandhi, S.; Gomez, D. R.; Chang, J. Y.; Blumenschein, G.; Rice, D.; O'Reilly, M.; Sepesi, B.; Lin, S. H. H.; Liao, Z.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

SAABR: Single arm phase II study of androgen receptor pathway inhibitor (ARPI) + atezolizumab + GnRH analog (ADT) and stereotactic body radiotherapy (SBRT) to the prostate in men with de novo hormone-sensitive metastatic prostate cancer (mHSPC)

Meeting Abstract

Rathkopf, D.; Dallos, M.; Stein, M.; Spina, C. S.; Deutsch, I.; Nguyen, C.; Okada, A.; Lloyd, M.; Manarite, J.; McBride, S.
Annals of Oncology (2024)

Fulltext@MSK | Save

Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum

Meeting Abstract

Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

TRIDENT: Machine learning (ML) multimodal signatures to identify patients that would benefit most from tremelimumab (T) addition to durvalumab (D) + chemotherapy (CT) with data from the POSEIDON trial

Meeting Abstract

Skoulidis, F.; Jabbour, S.; Garon, E. B.; Iyengar, P.; Scagliotti, G.; Ferrer, L.; Etchepare, G.; Gallinato, O.; Faure, J.; Bernard, P.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC

Meeting Abstract

Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
Annals of Oncology (2024)

Fulltext@MSK | Save

Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Dunn, L.; Cracchiolo, J.; Ho, A. L.; Sherman, E. J.; Ganly, I.; Ghossein, R.; Cohen, M.; Wong, W.; Desilets, A.; Michel, L.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial

Meeting Abstract

Senan, S.; Spigel, D. R.; Cho, B. C.; Laktionov, K.; Zenke, Y.; Lee, K. H.; Wang, Q.; Navarro Mendivil, A. F.; Buchmeier, E. L.; Sezgin Goksu, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Radiation therapy in a new era of multiple myeloma management: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response

Meeting Abstract

Dreyfuss, A.; Fregonese, B.; Usmani, S. Z.; Mailankody, S.; Imber, B. S.; Yahalom, J.
Blood (2024)

Fulltext@MSK | Save

Molecular features are associated with disease stage in diffuse large B-cell lymphoma and reveal heterogeneity in patient outcomes

Meeting Abstract

Uppal, M.; Gurumurthi, A.; Hamlin, P. A.; Falchi, L.; Horwitz, S.; Kumar, A.; Noy, A.; Lue, J. K.; Torka, P.; Arcila, M. E.; more...
Blood (2024)

Fulltext@MSK | Save

Radiation therapy for Burkitt lymphoma: Multi-decade insights from a single center

Meeting Abstract

Tward, A.; Patel, R. R.; Isgor, I.; Galera, P.; Lopez, K.; Fregonese, B.; Moore, Z.; Wolden, S.; Yahalom, J.; Imber, B. S.
Blood (2024)

Fulltext@MSK | Save